F

First Wave BioPharma, Inc.

14 employees

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).

Basic info

pharmaceutical manufacturing

Biotechnology

exocrine pancreatic insufficiency

Recombinant proteins

Health Care

chronic pancreatitis

COVID-19 GI infections

niclosamide

Lipase

pancreatic enzyme replacement therapy

Wellness

Non-sytemic therapies

cystic fibrosis

Medical

immune checkpoint inhibitor colitis

2014

$2.6M

from 1 investors over 1 rounds

F

First Wave BioPharma, Inc. raised $2.6M on September 6, 2018

Investors: Omega Funds